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Human Plasmacytoid Dendritic Cells Express
Receptors for Anaphylatoxins C3a and C5a
and Are Chemoattracted to C3a and C5a
Ralf Gutzmer1, Brigitta Ko¨ther1, Jo¨rg Zwirner2, Dorothea Dijkstra1, Rahul Purwar1, Miriam Wittmann1 and
Thomas Werfel1
The presence of plasmacytoid dendritic cells (pDC) was recently demonstrated in lesions of inflammatory skin
diseases. Since anaphylatoxins or their precursors were also found in such lesions, we investigated a possible
interaction between pDC and anaphylatoxins C3a and C5a. pDC precursors isolated from peripheral blood did
not express the receptors for C3a and C5a, complement C3a receptor (C3aR) and complement C3a receptor
(C5aR). If these pDC precursors were cultured with IL-3, the resultant immature pDC expressed both receptors.
Expression of C3aR and C5aR could also be demonstrated on pDC in lesions of cutaneous lupus erythematosus
and allergic contact dermatitis. Such pDC were immature since they lacked the expression of the maturation
marker CD83. Blood-derived pDC matured with CpG oligonucleotides downregulated the receptors. Immature
pDC responded to C3a and C5a (but not C3adesArg) stimulation with increased F-actin polymerization and
chemotactic migration. In contrast, interferon alpha production, surface molecule expression, and T-cell
stimulatory capacity were not significantly modulated by C3a or C5a. Thus, immature pDC represent another
type of antigen-presenting cell that express C3aR and C5aR, and respond to anaphylatoxins with chemotaxis.
This might be relevant in the direction of pDC to cutaneous lesions of inflammation, for example, in lupus
erythematosus or contact dermatitis.
Journal of Investigative Dermatology (2006) 126, 2422–2429. doi:10.1038/sj.jid.5700416; published online 15 June 2006
INTRODUCTION
Plasmacytoid dendritic cells (pDC) are a variant of antigen-
presenting cells that have been found in inflammatory skin
lesions, for example, of lupus erythematosus, allergic contact
dermatitis, atopic dermatitis, and psoriasis (Wollenberg et al.,
2002; Bangert et al., 2003; Nestle et al., 2005; Stary et al.,
2005). They differ from myeloid dendritic cells with regard to
morphology, surface marker expression, and cytokine produc-
tion (Colonna et al., 2004). Human pDC have a plasma cell-
like morphology rather than a veiled appearance, express Toll-
like receptor 9 (TLR-9), the IL-3 receptor a-chain (CD123),
BDCA-2, and BDCA-4, but lack TLR-2, TLR-3, TLR-4, TLR-5,
and CD11c. They produce primarily type I interferons in
response to pathogens or motifs such as CpG oligonucleotides
that stimulate TLR-9. pDC precursors can be isolated from
peripheral blood, but undergo rapid apoptosis in culture
unless rescued by addition of IL-3 to the culture medium
(Grouard et al., 1997; Rissoan et al., 1999). While cultured in
IL-3 containing medium, pDC precursors acquire an immature
phenotype with upregulation of costimulatory molecules such
as CD80, CD86, and CD40, while major histocompatibility
complex class II, interferon alpha production, and stimulatory
capacity in the mixed leukocyte reaction are not affected
(Grouard et al., 1997; Rissoan et al., 1999). Stimuli such as
CD40-ligand, viruses, or CpG oligonucleotides (Grouard
et al., 1997; Rissoan et al., 1999; Colonna et al., 2004), lead
to maturation of pDC. They further upregulate costimulatory
molecules and major histocompatibility complex class II,
increase their T-cell stimulatory capacity, increase interferon
alpha production (Grouard et al., 1997; Rissoan et al., 1999),
and upregulate the expression of lymph node homing
molecules such as CCR7 (Colonna et al., 2004).
The migration of pDC is poorly understood thus far
(Colonna et al., 2004), and it is in particular unclear, how
they are directed to inflammatory skin lesions. An interaction
between pDC and the anaphylatoxins C3a and C5a relevant
for migration and function of pDC is reasonable, since (1)
increased levels of anaphylatoxins or their precursors have
been found in human skin lesions of eczema, vasculitis, and
lupus erythematosus (Ring et al., 1978; Secher et al., 1978;
Williams et al., 1989) and (2) the receptors for C3a and C5a
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are expressed on other types of antigen-presenting cells, in
particular on B-cells (Fischer and Hugli, 1997), monocytes,
and macrophages (Wittmann et al., 1999; Soruri et al., 2003),
dendritic cells in the skin (Kirchhoff et al., 2001), and
monocyte derived dendritic cells (Weinmann et al., 2003;
Gutzmer et al., 2004). On these antigen-presenting cells, C3a
and C5a induce chemotaxis (Soruri et al., 2003; Weinmann
et al., 2003; Gutzmer et al., 2004), but can also modulate the
immune response (Fischer and Hugli, 1997; Wittmann et al.,
1999; Hawlisch et al., 2005). Furthermore, in C3- and
complement C3a receptor (C3aR)-deficient mice, a role for
C3 in promoting a Th2 immune reaction has been shown
(Kawamoto et al., 2004) and an antagonist to C3a signifi-
cantly reduced inflammation in a murine model of experi-
mental lupus nephritis (Bao et al., 2005).
We show here that the receptors for C3a and C5a, C3aR,
and complement C5a receptor (C5aR) are expressed on
immature pDC (obtained from peripheral blood precursors
after culture in IL-3) and on pDC in cutaneous lesions of
allergic contact dermatitis and lupus erythematosus, but not
on pDC precursors in peripheral blood. Both receptors are
downregulated after maturation of pDC with the TLR-9 ligand
CpG, while the maturation marker CD83 and the chemokine
receptor CCR7 are upregulated. Stimulation of pDC with C3a
and C5a (but not with C3adesArg) results in F-actin
polymerization and chemotactic migration, but immuno-
modulatory effects on interferon alpha production, cell
surface molecule expression, or T-cell stimulatory capacity
of pDC were not observed.
Thus, the anaphylatoxins C3a and C5a might represent a
new mechanism to recruit pDC to sites of inflammation.
RESULTS
Expression of C3aR and C5aR on pDC of blood and skin
pDC precursors freshly isolated from peripheral blood of
healthy donors did not express C3aR and C5aR (Figure 1).
After culture of pDC precursors in medium containing IL-3,
immature pDC developed that downregulated BDCA2
(Figure 1) (Dzionek et al., 2000). Such immature pDC
expressed both the C3aR and the C5aR (Figure 1). To answer
the question if there were also naturally occurring pDC that
expressed the C3aR and C5aR, we analyzed cells from
inflammatory skin lesions that have been shown to contain
pDC, that is, lesional skin of allergic contact dermatitis and
cutaneous lupus erythematosus (Wollenberg et al., 2002;
Bangert et al., 2003). By four-color flow cytometry, we were
able to identify pDC expressing C3aR and C5aR in skin
lesions of lupus erythematosus and contact dermatitis
(Figure 2). These cutaneous pDC were immature, since they
lacked the expression of the maturation marker CD83
(Figure 3).
Upon in vitro maturation of pDC isolated from peripheral
blood using the TLR-9 ligand CpG as maturation stimulus,
pDC upregulated the maturation marker CD83 and the
chemokine receptor CCR-7 as reported in previous studies
(Penna et al., 2001). Mature pDC also downregulated C3aR
and C5aR compared to immature pDC (Figure 4). Thus,
anaphylatoxin receptor expression was confined mainly to
immature pDC and these cells were used for further
functional studies.
Effect of C3a and C5a on calcium influx of pDC
Induction of calcium influx has been described for both C5a
and C3a on other cell types. Therefore, we employed a
calcium influx assay to test functionality of C3aR and C5aR
on pDC. C5a but not C3a induced calcium influx in pDC
(Figure 5).
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Figure 1. Expression of C3aR and C5aR on pDC isolated from peripheral
blood. (a) pDC were isolated from peripheral blood mononuclear cell and
stained for flow cytometry either immediately after isolation or after 24 and
48 hours culture in the presence of IL-3. Staining was performed for CD123/
IL-3 receptor (in CyChrome for detection in the FL-3 channel) and BDCA2 (in
PE for detection in the FL-2 channel) as demonstrated in the dot plots. The
histograms show fluorescence in the FL-1 channel for C3aR-FITC (dotted line),
C5aR-FITC (black line), and the appropriate isotype control (gray line). Freshly
isolated pDC precursors do not express the anaphylatoxin receptors). (b and c)
Upon culture with IL-3, immature pDC develop that downregulate BDCA-2
and upregulate C3aR and C5aR . One representative experiment out of five is
shown.
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Chemotactic effects of C3a and C5a on pDC
The effect of C3a and C5a on the migratory capacity
of immature pDC was assessed by two different assays: first,
by determination of F-actin polymerization induced by
C3a and C5a as parameter for cytoskeleton reorganization
and indirect marker for cell migration; second, by deter-
mination of cell migration in Boyden chamber chemotaxis
assays.
C3a and C5a but not C3adesArg induced F-actin
polymerization in immature pDC (Figure 6a). F-actin poly-
merization was significantly reduced in mature pDC as
compared to immature pDC (Figure 6b), corresponding to the
downregulation of C3aR and C5aR expression on mature
pDC. Immature pDC migrated towards gradients of C3a and
C5a (but not C3adesArg) in Boyden chamber assays (Figure 7).
Immunomodulatory effects of C3a and C5a on pDC
The effects of C3a and C5a on interferon alpha production,
surface marker expression and T-cell stimulatory capacity of
pDC were evaluated.
With regard to interferon alpha, C3a, and C5a did neither
induce nor block CpG-induced production, while CpG
induced a high amount of interferon alpha (data not shown).
With regard to surface marker expression, CpG signifi-
cantly upregulated major histocompatibility complex class II,
maturation marker CD83, and costimulatory molecules
CD40, CD80, and CD86. However, C3a, C5a, and C3ades-
Arg had no significant effect (data not shown).
Furthermore, prestimulation of immature pDC with C3a
and C5a did not result in an increased proliferation or altered
IL-4 or interferon gamma production of naı¨ve allogeneic
T-cells in coculture experiments, whereas the maturation
stimulus CpG significantly increased the capacity of pDC to
stimulate T-cell proliferation and interferon gamma produc-
tion (data not shown).
DISCUSSION
Increased numbers of pDC have been described in lesions of
inflammatory skin diseases, for example, in allergic contact
dermatitis (Wollenberg et al., 2002; Bangert et al., 2003),
atopic dermatitis (Stary et al., 2005), psoriasis (Wollenberg
et al., 2002; Nestle et al., 2005), and cutaneous lupus
erythematosus (Farkas et al., 2001; Wollenberg et al., 2002).
The recruitment of pDC to such inflammatory lesions is not
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Figure 2. C3aR and C5aR are expressed on pDC in inflammatory skin
lesions. Single-cell suspensions obtained from inflammatory skin lesions were
stained with four colors and analyzed by flow cytometry. Staining was
performed with C3aR-FITC or C5aR-FITC (for detection in the FL-1 channel),
with lineage markers including CD3, CD14, CD16, and CD19 in PE (for
detection in the FL-2 channel), with HLA-DR-CyChrome (for detection in the
FL-3 channel) and with BDCA4-APC (for detection in the FL-4 channel). The
lineage-marker negative population expressing (a) HLA-DR and (b) BDCA4
was defined as plasmacytoid dendritic cells. (c) C3aR- and C5aR-expression
on this population is shown in the histogram with C3aR-FITC as dotted line,
C5aR-FITC as black line, and isotype control as gray line. (a–c) One
representative experiment from a patient with contact dermatitis is shown.
(d) Six experiments from independent donors, black lines indicate patients
with contact dermatitis (n¼ 4), gray lines patients with cutaneous lupus
erythematosus (n¼2) are summarized. Differences in mean fluorescence
intensity comparing isotype control and C3aR- or C5aR staining are
statistically significant.
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Figure 3. pDC in inflammatory skin lesions are immature. Single cells
suspensions were obtained from inflammatory skin lesions, pDC were
identified by flow cytometry as shown in Figure 2. Staining in the FL-1
channel was performed with (a) C3aR-FITC or C5aR-FITC control or with the
maturation marker (b) CD83-FITC. pDC in inflammatory skin lesions express
C3aR and C5aR but not the maturation marker CD83. One representative
experiment of a patient with contact dermatitis (n¼ 4) is shown.
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clear, in particular since most studies investigated the
migration of pDC precursors freshly isolated from peripheral
blood (Penna et al., 2001; Vanbervliet et al., 2003). Receptors
for inflammatory chemokines such as CXCR3, CCR2, and
CCR5 are expressed on human pDC precursors (Cella et al.,
1999; Penna et al., 2001; Zou et al., 2001) but failed to
mediate chemotaxis in vitro (Penna et al., 2001; Krug et al.,
2002; Vanbervliet et al., 2003). Recently, it has been shown
that triggering of CXCR4 on pDC precursors by SDF-1/
CXCL12 facilitates migration of pDC towards CXCR3 ligands
such as the inducible chemokines Mig/CXCL9, IP-10/
CXCL10, and ITAC/CXCL11 (Krug et al., 2002; Vanbervliet
et al., 2003). This could result in migration of pDC to sites of
inflammation, since the CXCR4 ligand SDF-1/CXCL12 is
constitutively expressed in endothelial cells and perivascular
cells of the skin (Pablos et al., 1999).
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Figure 4. Effect of maturation on C3aR and C5aR expression of pDC isolated
from peripheral blood. pDC isolated from peripheral blood were cultured for
48 hours with IL-3 either in the absence or presence of the maturation
stimulus CpG. Staining for flow cytometry was performed with the maturation
marker CD83-APC (for detection in the FL-4 channel) and the chemokine
receptor expressed on mature DC, CCR-7-PE (for detection in the FL-2
channel), as demonstrated in the dot plots. The histograms show fluorescence
in the FL-1 channel for C3aR-FITC (dotted line), C5aR-FITC (black line), and
the isotype control (gray line). (a) Immature pDC expressed C3aR and C5aR,
(b and c) whereas pDC matured with CpG downregulated the anaphylatoxin
receptors but upregulated CD83 and CCR-7. (a–c) One representative
experiment is shown. (d) Four different experiments (the mean fluorescence
intensity of the specific staining after subtraction of the corresponding isotype
staining is shown, differences are statistically significant).
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Figure 5. C5a induces calcium influx in pDC. Immature pDC were
stimulated with C5a, C3a, C3adesArg (at a concentration of 1 mg/ml), medium
(as negative control) and calcium ionophore (at a concentration of 3 mM as
positive control). C5a and calcium ionophore but not C3a, C3adesArg, and
medium induced calcium influx (note the different Y-axis scales). One
representative experiment out of four is shown.
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Another report showed expression of ChemR3 on human
pDC precursors and pDC matured with influenza virus, but
only pDC precursors migrated towards the ChemR23 ligand
chemerin (Vermi et al., 2005). Chemerin was expressed in
high endothelial venoles of lymph nodes and in dermal
endothelial cells of cutaneous lesions of lupus erythematosus,
but not in normal skin (Vermi et al., 2005). Thus, there are at
present two chemotactic receptors on pDC precursors known
that are per se functional, CXCR4, and ChemR3.
We describe here a new mechanism that could account
for the accumulation of pDC in lesions of inflammatory skin
diseases. We show that immature pDC derived from pDC
precursors from peripheral blood by culture in IL-3 contain-
ing medium upregulate the anaphylatoxin receptors for C3a
and C5a. Freshly isolated pDC precursors in peripheral blood
did not express C3aR and C5aR, which is in line with a
previous publication (Schakel et al., 2002). We could also
demonstrate expression of C3aR and C5aR on pDC in
cutaneous lesions of lupus erythematosus and allergic contact
dermatitis, suggesting that expression of these receptors is
biologically relevant. These pDC resemble immature pDC
since they lack expression of the maturation marker CD83. In
contrast, fully mature pDC that express CD83 downregulate
C3aR and C5aR expression, indicating that expression and
function of these receptors is mainly confined to immature
pDC. It is unclear, however, which stimuli upregulate
anaphylatoxin receptors on pDC precursors in vivo. IL-3
could be a candidate for the in vivo situation, since it plays a
role in delayed type hypersensitivity (Mach et al., 1998) and
could also be relevant in lupus erythematosus (Fishman et al.,
1993).
The primary effect of C3a and C5a on pDC demonstrated
in our study was induction of F-actin polymerization and
chemotactic migration in vitro. A chemotactic effect of C3a
and C5a has previously been shown on other antigen-
presenting cells, in particular on dendritic cells (Soruri et al.,
2003; Weinmann et al., 2003; Gutzmer et al., 2004). Thus,
pDC represent another target cell that might be recruited by
C3a and C5a to peripheral sites of inflammation, for example,
in the skin. C3a and C5a or their precursors can be produced
and released in the skin (Terui et al., 1997). They have been
described in cutaneous lesions of lupus erythematosus
(Williams et al., 1989), allergic dermatitis (Ring et al.,
1978; Secher et al., 1978; Terui et al., 1997), and psoriasis
(Mrowietz et al., 2001), where also increased numbers of
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Figure 6. C3a and C5a induce F-actin polymerization in pDC. (a) In Figure
6a, pDC were immature, that is, they were differentiated from pDC precursors
isolated from peripheral blood by culture in medium with IL-3 for 2 days. pDC
were stimulated with C3a, C5a, C3adesArg, or buffer, respectively, for the
indicated period of times. Following stimulation, cells were fixed, stained
with nitrobenzoxadiazole-phallacidin and FL-1 fluorescence was detected as
measure for F-actin content as described in Materials and Methods. Relative
F-actin content is expressed as the ratio of the mean channel fluorescence
(¼ integrated fluorescence) between stimulated and nonstimulated cells. C3a
and C5a but not C3adesArg and medium induced a significant F-actin
polymerization in immature pDC. Mean7SEM. of six independent
experiments are shown, * indicates significant differences in comparison
to the medium control. (b) Immature pDC (obtained by incubation of pDC
precursors with IL-3 for 48 hours) were compared to mature pDC (cultured for
48 hours in IL-3 and CpG containing medium). Cells were stimulated with
C3a and C5a for 30 seconds and relative F-actin content was determined.
Immature pDC but not CpG matured pDC respond to anaphylatoxin
stimulation by significant F-actin polymerization. Mean7SEM of five
independent experiments are shown, * indicates significant differences in
comparison to the medium control.
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Figure 7. C3a and C5a induce chemotacic migration of pDC in Boyden
chamber assays. For measurement of chemotaxis, immature pDC (obtained
from pDC precursors isolated from peripheral blood after 2 days in culture
with IL-3) were fluorescently labelled with calcein and 1 105 pDC were
exposed to gradients of C3a, C5a, or C3adesArg, respectively, in Boyden
chambers for 90 minutes. Buffer served as background control. Migrated cells
in the lower part of the Boyden chambers were determined according to the
calcein fluorescence as described in Materials and Methods. Mean7SEM of
four independent experiments are shown. * indicates significant differences in
comparison to the medium control. C3a and C5a but nor C3adesArg induced
a significant cell migration of pDC.
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pDC have been observed. Thus, it is possible that C3a and
C5a play a role in the recruitment of pDC to inflammatory
skin lesions.
In contrast to migration, we were unable to detect any
immunomodulatory effects of C3a and C5a on pDC with
regard to interferon alpha production, surface marker
expression, and priming of T-cell proliferation and polariza-
tion under conditions where CpG yielded high interferon
alpha production, upregulation of CD80, CD86, CD40,
CD83, and major histocompatibility complex class II,
increased T-cell proliferation, and Th1-polarization, as
expected for a maturation stimulus (Colonna et al., 2004).
Interestingly, C5a but not C3a induced calcium influx in
immature pDC. The induction of multiple, calcium depen-
dent and independent, signaling pathways by C5a was also
described for monocytes (Monk et al., 1994).
In summary, we showed the expression of the
anaphylatoxin receptors for C3a and C5a on human
immature pDC and their downregulation upon maturation
with TLR-9 ligand CpG. Stimulation of pDC with C3a and
C5a resulted in F-actin polymerization and migration in
Boyden chamber assays. Thus, pDC represent a novel target
cell that might be attracted by anaphylatoxins to sites of
inflammation.
MATERIALS AND METHODS
Isolation of pDC from peripheral blood
Peripheral blood mononuclear cells were isolated by Lymphoprep
density gradient centrifugation of heparinized leukocyte-enriched
buffy-coats. From these peripheral blood mononuclear cell, pDC
precursors were isolated using the BDCA-4 cell isolation kit from
Miltenyi Biotech (Bergisch Gladbach, Germany). The cells obtained
were either immediately analyzed or cultured in IL-3 (10 ng/ml,
Immunotools, Friesoythe, Germany) containing Iscoves medium
(supplemented with 4% heat inactivated human serum) for
24–48 hours. Freshly isolated pDC precursors had a purity of at least
90% based upon expression of CD123, BDCA-2 and HLA-DR, and
lack of expression of CD3, CD14, CD16 and CD19. pDC precursors
isolated from peripheral blood were defined as ‘‘immature pDC’’
after culture for 48 hours in IL-3 containing medium.
Stimulation of pDC and FACS analysis
Previous studies have shown that pDC express TLR-9 and stimulation
of pDC with TLR-9 ligands such as CpG oligonucleotides results in
maturation and interferon alpha production of pDC (Colonna et al.,
2004). We used CpG oligonucleotide ODN2216 as maturation
stimulus for pDC at a concentration of 10 mg/ml. The CpG
oligonucleotide ODN2216 has the sequence of ODN2216 is
50-ggGGGACGATCGTCgggggG-30 (capital letters, phosphodiester
linkage 30 of the base; small letters, phosphothioate linkage 30 of the
base) (synthesized by TIBMOLBIOL, Berlin, Germany) and is
abbreviated with CpG throughout the manuscript. pDC were defined
as ‘‘mature pDC’’ after 24–48 hours culture in medium containing
IL-3 and CpG.
C3a, C5a, C3adesArg (used routinely at 1 mg/ml and at different
concentrations as indicated) were obtained from Calbiochem
(Schwalbach, Germany) and free of endotoxin as demonstrated
with the Limulus assay (Coatest Endotoxin, Pharmacia, Freiburg,
Germany). C3adesArg was used as negative control since it does not
bind the C3aR (Wilken et al., 1999).
For flow cytometry, cells (1–2 105) were washed and resus-
pended in phosphate-buffered saline (PBS) containing
0.2% gelatine, 20 mM sodium azide, and 10mg/ml heat-aggregated
human IgG (Sigma, Deisenhofen, Germany) for 15 minutes.
Subsequently, cells were incubated with fluorescent labeled anti-
bodies on ice for 30 minutes (CD3-PE, CD11c-FITC, CD14-PE,
CD16-PE, CD19-PE, CD40-PE, CD80-FITC, CD83-APC, CD86-PE,
and isotype matched controls from Immunotech, Hamburg,
Germany; CCR-7-PE from R&D Systems, Wiesbaden, Germany,
CD123-CyChrome, HLA-DR-FITC, and HLA-DR-CyChrome
from Becton Dickinson, Heidelberg, Germany, BDCA2-PE and
BDCA4-APC from Miltenyi). C5aR-FITC and C3aR-FITC antibodies
were produced and characterized as stated previously
(Weinmann et al., 2003; Gutzmer et al., 2004). Stained cells were
washed three times, fixed in PBS with 1% paraformaldehyde and
analyzed by flow cytometry (FACS Calibur, Becton Dickinson,
Heidelberg, Germany).
Preparation of cutaneous cell suspensions and assessment of
C3aR and C5aR expression on pDC from inflammatory skin
lesions
Skin biopsies were obtained from lesional skin of patients with
allergic contact dermatitis and subacute cutaneous lupus erythema-
tosus. The study was approved by the local Ethics Committee of
Hannover Medical School. The Declaration of Helsinki Principles
were followed and informed written consent was obtained from
each participating subject.
In local anesthesia, shave biopsies of epidermis and upper dermis
were obtained, cut in small pieces, and immediately transferred in
Hank’s solution with 0.25% trypsin (Sigma) for 20 minutes at 371C.
The reaction was quenched by addition of 10% fetal bovine serum, a
single-cell suspension was obtained by repetitive pipetting and using
a cell strainer with 40 mm pore size.
The resulting cell suspension was immediately stained for FACS
analysis with FITC labeled antibodies to C3aR, C5aR, CD83, or
isotype control, respectively. To allow identification of pDC, an
antibody cocktail with CD3-PE, CD14-PE, CD16-PE, CD19-PE,
HLA-DR-CyChrome, and BDCA-4-APC was used. Cells negative for
the PE labeled markers and positive for HLA-DR and BDCA-4 were
regarded as pDC.
Calcium release assay
pDC were isolated from peripheral blood and incubated with IL-3 for
48 hours. The resulting immature pDC were washed in PBS
supplemented with 1 mM clcium chloride, 1 mM magnesium
chloride, and 1% bovine serum albumine (Sigma) (calcium influx
buffer), resuspended at 1 106 cells/ml in calcium influx buffer and
loaded with 5mM Fluo-4 AM (Molecular Probes, Karlsruhe,
Germany) in for 30 minutes at 371C in the dark. Cells were washed
in calcium influx buffer and seeded in 96-well black plates (Costar,
Bethesda, MD; 1–2 105 cells/well). The plate was then centrifuged
for 1 minute. The cells were placed in the FLUOstar (BMG
Labtechnologies, Offenburg, Germany), stimulated with C3a, C5a,
C3adesArg (at 1mg/ml, respectively), calcium ionophore (3 mM,
Sigma), or medium, and changes in cellular fluorescence were
recorded at 485 nm.
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Assessment of F-actin polymerization
Nitrobenzoxadiazole-phallacidin (MoBiTec, Go¨ttingen, Germany)
staining of pDC was carried out as described previously (Weinmann
et al., 2003; Gutzmer et al., 2004). Briefly, cells were resuspended at
a concentration of 2 106 cells/ml in PBS-buffer lacking Ca2þ and
were stimulated with the indicated stimulus for different periods of
time at room temperature. Following stimulation, cells were fixed
using 3.7% formaldehyde for 60 minutes. Lysophosphatidylcholine
(20 mg/ml, Sigma) and 3.7 107 M nitrobenzoxadiazole-phallacidin
were added to the sample and incubated for a period of 60 minutes
in the dark. Nitrobenzoxadiazole-phallacidin-stained cells were
analyzed on a Becton Dickinson FACScan with a linear fluorescence
channel (FL-1), where the fluorescence is proportional to F-actin
content. Relative F-actin content is expressed as the ratio of the mean
channel fluorescence (¼ integrated fluorescence) between stimu-
lated and nonstimulated cells.
Boyden chamber chemotaxis assays
Chemotactic activity of pDC was determined using a microchamber
technique as described previously (Frevert et al., 1998). In brief,
isolated pDC precursors were cultured for 48 hours in medium
containing IL-3. Then, 2 106 pDC/ml were incubated in PBS with
2mM calcein (MoBiTec) for 30 minutes at 371C. A measure of 27 ml of
the chemotactic stimulus or control medium (PBS) was filled in the
bottom chamber of disposable 96-well plates (NeuroProbe, Bethes-
da, MD) and covered with a polycarbonate filter with a pore size of
5mm. 1 105 labelled pDC were loaded in 25 ml on top of the
membrane. After incubation for 90 minutes at 371C, remaining cells
on top of the membranes were removed by wiping. Calcein
fluorescence in the bottom chamber was measured using the
FLUOstar Galaxy (BMG Labtechnologies, Offenburg, Germany).
For calculation of the number of migrated cells, equivalent to calcein
fluorescence determined in the lower parts of the Boyden chambers,
values were calculated from a standard curve using known numbers
of pDC.
Assessment of interferon alpha production
2 105 immature pDC (precursor pDC isolated from peripheral
blood cultured in IL-3 containing medium for 48 hours) were either
not stimulated or stimulated with C3a, C5a, C3adesArg (as negative
control) or CpG (as positive control) for 24 hours. Supernatants were
harvested after 24 hours and analyzed for interferon alpha using a
commercially available ELISA (PBL Biomedical Laboratories, New
Brunswick, NJ).
Assessment of surface molecule expression
2 105 immature pDC were either not stimulated or stimulated with
C3a, C5a, C3adesArg (as negative control) or CpG (as positive
control) for 24 hours. Cells were stained and analyzed by flow
cytometry.
Allogeneic proliferation and polarization assay
Immature pDC were stimulated for 24 hours with C3a, C5a,
C3adesArg, or CpG (as positive control). Naı¨ve, allogeneic CD4þ
T-cells were separated from nonadherent cells of buffy coats using a
commercially available kit following the manufacturers’ instructions
(Miltenyi Biotech, Bergisch Gladbach, Germany). The purity of
CD4þ T-cells was at least 95% as controlled by flow cytometry. The
isolated T-cells were labeled with carboxyfluorescein diacetate
succinimidyl ester (MoBiTec) by incubating 1 107 cells/ml with
1mM carboxyfluorescein diacetate succinimidyl ester in the dark for
90 seconds. The reaction was quenched with the same volume of
fetal calf serum for 1 minute afterwards the cells were washed two
times in Iscoves medium and resuspended in Iscoves medium
supplemented with 4% human serum.
105 T-cells were added to 2 104 prestimulated and
washed pDC per well in 96-well culture plates. T-cells and
pDC were cocultured for 5 days, then either cells were
analyzed by flow cytometry for cell proliferation by measuring
carboxyfluorescein diacetate succinimidyl ester fluorescence or
restimulated with 10 ng/ml PMA and 400 ng/ml Ionomycin (both
from Sigma) overnight. Supernatants from these restimulated
cocultures were than assayed for interferon gamma and IL-4 content
by ELISA.
Statistical analysis
Statistical analyzes were performed using the paired T-test.
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